IL6 and AA amyloidosis: Production of SAA is induced by inflammatory mediators such as TNF-alpha, IL-1, and IL-6 that are chronically and persistently elevated in a wide range of chronic inflammatory diseases, including Castleman disease (CD).[3,4] Treatment of AA amyloidosis is directed at controlling or eliminating the underlying inflammatory disease.